The results of the study could improve immunotherapy treatment for patients with colorectal and other barrier-tissue cancers.

Small cell lung cancer (SCLC) is one of the most aggressive forms of lung cancer, with a five-year survival rate of only 5%.

A new research paper was published in Volume 12 of Oncoscience on October 14, 2025, titled "Bridging clinical insight and laboratory model in high-grade serous ovarian carcinoma (HGSOC) using DNA ...

A bacterium living quietly in the intestines of a tiny tree frog has done something cancer researchers spend careers chasing: ...

Scientists showed that using new molecules that block an immune "checkpoint" could stimulate a "strong" anti-tumor immune ...